InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Benatti Luca, Director. Officer active across 2 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 6 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €147k. History available since 27 May 2021. The latest transaction was disclosed on 26 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Benatti Luca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
8,918 sharesCommon StockSEC:0000912282-25-001468:0
50,000 shares@ US$3.47100.0% of flowCommon StockSEC:0000912282-25-001469:0
25,487 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117110:0
8,111 shares0Common StockSEC:0001104659-23-064846:0
7,737 shares0Common StockSEC:0001104659-22-065918:0
7,029 shares0Common StockSEC:0001104659-21-075215:0
6 of 6 declarations
About Benatti Luca
Luca Benatti is a Director at INTERCEPT PHARMACEUTICALS, INC. In this role, he participates in the governance and strategy of the company. INTERCEPT PHARMACEUTICALS, INC. is a biopharmaceutical company specializing in developing treatments for liver diseases. Luca Benatti brings his expertise in health to help guide strategic decisions.
